Literature DB >> 22581205

Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results.

Myung Ho Rho1, Dong Wook Kim, Hyun Pyo Hong, Young Mi Park, Min Jeong Kwon, Soo Jin Jung, Young Wook Kim, Taewoo Kang.   

Abstract

Detection of antithyroid peroxidase antibody (TPOAb) is widely used in the diagnosis of autoimmune thyroiditis (AIT), but no research has evaluated the diagnostic accuracy of TPOAb detection using histopathologic reference standards. To fill this research gap, this study assessed the diagnostic accuracy of detection of TPOAb and that of other serological markers in asymptomatic patients who had been diagnosed with AIT by histopathologic analysis after thyroid surgery. After review of patient records, 598 patients who had undergone thyroid nodule surgery were enrolled for examination for thyroid parenchyma by a pathologist and classification into no co-existing lymphocytic thyroiditis, Hashimoto thyroiditis, or non-Hashimoto type of lymphocytic thyroiditis (NHLT). The correlation between patient serological data and thyroid parenchyma pathology was analyzed. Statistically significant differences (P < 0.05) were found between co-existing lymphocytic thyroiditis and no co-existing lymphocytic thyroiditis groups regarding thyroid-stimulating hormone (TSH) and TPOAb levels. And, TPOAb titer was significantly associated with the degree of inflammation. An abnormal TPOAb titer was found in 86 of the 598 patients (14.4 %) and the specificity of TPOAb detection for AIT diagnosis was found to be 96.9 %. The prevalence of Hashimoto thyroiditis and NHLT in the 560 papillary thyroid cancer (PTC) patients was found to be 7.9 and 17.9 %, respectively. The results indicate that TPOAb titer is associated with the degree of thyroid inflammation and that detection of TPOAb is a very specific means of diagnosing AIT. The results also indicate that the incidence of AIT and PTC coexistence is relatively high.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581205     DOI: 10.1007/s12020-012-9695-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

1.  Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study.

Authors:  Elias E Mazokopakis; Anastasios A Tzortzinis; Elpida I Dalieraki-Ott; Athanasios N Tsartsalis; Periklis K Syros; Christos M Karefilakis; Maria G Papadomanolaki; Ioannis K Starakis
Journal:  Hormones (Athens)       Date:  2010 Oct-Dec       Impact factor: 2.885

2.  Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases.

Authors:  U Feldt-Rasmussen; M Høier-Madsen; K Bech; M Blichert-Toft; H Bliddal; J Date; B Danneskiold-Samsøe; L Hegedüs; E Hippe; P J Hornnes
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

3.  Serum thyrotrophin and circulating thyroglobulin and thyroid microsomal antibodies in a Finnish population.

Authors:  A Gordin; J Maatela; A Miettinen; T Helenius; B A Lamberg
Journal:  Acta Endocrinol (Copenh)       Date:  1979-01

Review 4.  Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations.

Authors:  D L Ward; R G Bing-You
Journal:  Endocr Pract       Date:  2001 Jan-Feb       Impact factor: 3.443

5.  Lithium-associated clinical hypothyroidism. Prevalence and risk factors.

Authors:  A M Johnston; J M Eagles
Journal:  Br J Psychiatry       Date:  1999-10       Impact factor: 9.319

6.  Euthyroid goiters in children: correlation of needle biopsy with other clinical and laboratory findings in chronic lymphocytic thyroiditis and simple goiter.

Authors:  S M Ling; S A Kaplan; J J Weitzman; G B Reed; G Costin; B H Landing
Journal:  Pediatrics       Date:  1969-11       Impact factor: 7.124

7.  The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland.

Authors:  S Matsubayashi; K Kawai; Y Matsumoto; T Mukuta; T Morita; K Hirai; F Matsuzuka; K Kakudoh; K Kuma; H Tamai
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

8.  Cytomorphologic study of Hashimoto's thyroiditis and its serologic correlation: a study of 150 cases.

Authors:  Neha Singh; Surendra Kumar; Vir Singh Negi; Neelaiah Siddaraju
Journal:  Acta Cytol       Date:  2009 Sep-Oct       Impact factor: 2.319

9.  Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans.

Authors:  I Okayasu; M Fujiwara; Y Hara; Y Tanaka; N R Rose
Journal:  Cancer       Date:  1995-12-01       Impact factor: 6.860

Review 10.  Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations.

Authors:  Won-Jin Moon; Jung Hwan Baek; So Lyung Jung; Dong Wook Kim; Eun Kyung Kim; Ji Young Kim; Jin Young Kwak; Jeong Hyun Lee; Joon Hyung Lee; Young Hen Lee; Dong Gyu Na; Jeong Seon Park; Sun Won Park
Journal:  Korean J Radiol       Date:  2011-01-03       Impact factor: 3.500

View more
  15 in total

1.  γδ Τ cells enhance B cells for antibody production in Hashimoto's thyroiditis, and retinoic acid induces apoptosis of the γδ Τ cell.

Authors:  Hongli Liu; Tingting Zheng; Yufei Mao; Chengcheng Xu; Fei Wu; Ling Bu; Xiao Mou; Yuepeng Zhou; Guoyue Yuan; Shengjun Wang; Tong Zhou; Deyu Chen; Chaoming Mao
Journal:  Endocrine       Date:  2015-05-21       Impact factor: 3.633

2.  A comprehensive score to diagnose Hashimoto's thyroiditis: a proposal.

Authors:  Giorgio Grani; Giovanni Carbotta; Angela Nesca; Mimma D'Alessandri; Martina Vitale; Marianna Del Sordo; Angela Fumarola
Journal:  Endocrine       Date:  2014-10-04       Impact factor: 3.633

3.  Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.

Authors:  Xiaoyu Wu; Yu Lun; Han Jiang; Qingwei Gang; Shijie Xin; Zhiquan Duan; Jian Zhang
Journal:  Endocrine       Date:  2013-12-14       Impact factor: 3.633

4.  Hyperhomocysteinemia in acute iatrogenic hypothyroidism: the relevance of thyroid autoimmunity.

Authors:  F Cicone; M G Santaguida; G My; G Mancuso; A Papa; R Persechino; C Virili; N Brusca; A Tofani; F Scopinaro; M Centanni
Journal:  J Endocrinol Invest       Date:  2017-12-29       Impact factor: 4.256

5.  Thyro-gastric autoimmunity in patients with differentiated thyroid cancer: a prospective study.

Authors:  Francesco Cicone; Annalisa Papa; Chiara Lauri; Anna Tofani; Camilla Virili; Marco Centanni; Francesco Scopinaro; Bruno Annibale
Journal:  Endocrine       Date:  2014-09-12       Impact factor: 3.633

6.  Evidence of impaired carbohydrate assimilation in euthyroid patients with Hashimoto's thyroiditis.

Authors:  S Heckl; C Reiners; A K Buck; A Schäfer; A Dick; M Scheurlen
Journal:  Eur J Clin Nutr       Date:  2015-10-07       Impact factor: 4.016

7.  Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas.

Authors:  Ju-Yeon Kim; Taejin Park; Sang-Ho Jeong; Chi-Young Jeong; Young-Tae Ju; Young-Joon Lee; Soon-Chan Hong; Woo-Song Ha; Sang-Kyung Choi; Eun Jung Jung
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

8.  Pathologic spectrum of lymphocytic infiltration and recurrence of papillary thyroid carcinoma.

Authors:  Hyun Gi Kim; Eun-Kyung Kim; Kyung Hwa Han; Hyunki Kim; Jin Young Kwak
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

9.  Correlation between thyroid autoantibodies and the risk of thyroid papillary carcinoma.

Authors:  Xuyang Peng; Xi Zhu; Feng Cheng; Bin Zhou; Xiaohua Zhu; Lei Zhu
Journal:  Gland Surg       Date:  2020-08

10.  Incidental thyroid carcinoma diagnosed after total thyroidectomy for benign thyroid diseases: incidence and association with thyroid disease type and laboratory markers.

Authors:  D Askitis; E I Efremidou; M Karanikas; A Mitrakas; G Tripsianis; A Polychronidis; N Liratzopoulos
Journal:  Int J Endocrinol       Date:  2013-11-20       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.